HRT Financial’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
119,775
-141,236
| -54% | -$1.59M | 0.01% | 926 |
|
|
2025
Q1 | $2.63M | Buy |
+261,011
| New | +$2.63M | 0.02% | 575 |
|
|
2024
Q1 | – | Sell |
-173,103
| Closed | -$1.94M | – | 2803 |
|
|
2023
Q4 | $1.94M | Buy |
+173,103
| New | +$1.94M | 0.01% | 622 |
|
|
2023
Q3 | – | Sell |
-635,470
| Closed | -$6.41M | – | 2732 |
|
|
2023
Q2 | $6.41M | Buy |
+635,470
| New | +$6.41M | 0.06% | 222 |
|
|
2022
Q4 | – | Sell |
-471,738
| Closed | -$1.52M | – | 2811 |
|
|
2022
Q3 | $1.52M | Buy |
471,738
+175,215
| +59% | +$564K | 0.02% | 683 |
|
|
2022
Q2 | $1.21M | Buy |
296,523
+56,315
| +23% | +$229K | 0.01% | 795 |
|
|
2022
Q1 | $1.19M | Buy |
+240,208
| New | +$1.19M | 0.01% | 823 |
|